Symposia

Friday, November 10, 2017

 

IBD: LEVERAGING NOVEL TARGETED THERAPIES FOR OPTIMIZED CLINICAL OUTCOMES

Northern Hemisphere Ballroom, C-D
Support by: Celgene Corporation
6:15 am – 7:40 am

MORE INFO

 

SEPARATING MYTH FROM FACT: CURRENT PERSPECTIVES IN THE MANAGEMENT OF ULCERATIVE COLITIS

Northern Hemisphere Ballroom, A-B
Support by: Takeda
6:15 am – 7:40 am

MORE INFO

 

HERE AND NOW: BIOSIMILARS FOR THE TREATMENT OF IBD

Northern Hemisphere Ballroom, A-B
Support by: Samsung Bioepis
12:45 pm – 1:45 pm

MORE INFO

 

NOVEL TARGETS FOR IBD THERAPY: IS THIS THE FINAL FRONTIER?

Northern Hemisphere Ballroom, C-D
Support by: Pfizer
12:45 pm – 1:45 pm

MORE INFO

 

THE PATH TO PERSONALIZED TREATMENT: PROMISING NEW DIRECTIONS FOR THE THERAPEUTIC MANAGEMENT OF CROHN’S DISEASE

Northern Hemisphere Ballroom, C-D
Support by: Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and AbbVie.
6:45 pm – 8:30 pm

MORE INFO

 

Saturday, November 11, 2017

 

IMPROVING IBD CARE: A PERSONALIZED APPROACH TO MANAGEMENT

Northern Hemisphere Ballroom, A-B
Support by: American Regent, Inc. and Pfizer Inc.   
12:45 pm – 1:45 pm

MORE INFO

 

ONGOING CHALLENGES IN THE MANAGEMENT OF UC (NON-ACCREDITED)

Northern Hemisphere Ballroom, C-D
Support by: Pfizer
12:45 pm – 1:45 pm

MORE INFO

 

 

Click here to download the 2017 Satellite Application

Click here to download the 2017 Satellite Guidelines (CME)

Click here to download the 2017 Satellite Guidelines (Non-CME)

For symposia requests, please contact Imedex:

Teresa Lovich
t.lovich@imedex.com
+1 (214) 679 8736